HIV/AIDS HAART
HAART associated with life-threatening maternal and fetal macrocytic anemia
Published in AIDS Weekly, January 9th, 2006
According to a recent report from the United States, "Antiretroviral therapy is recommended for human immunodeficiency virus (HIV)-infected patients during pregnancy to reduce the vertical transmission to the newborn. Complications from this therapy are uncommon."
"A 38-year-old HIV-positive pregnant woman was treated with lamivudine and zidovudine. At 28 weeks of gestation, her hemoglobin had fallen to 4.6 g/dL with a mean corpuscular volume (MCV) of 126 mcm.
"At 36 weeks the fetal biophysical profile was abnormal. A pale hydropic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-01-09)
More Articles from AIDS Weekly
- HIV/AIDS Drug Resistance
Genetic variants may predict virologic failure and/or emergence of drug-resistant HIV - HIV/AIDS Pathogenesis
HIV virions without the nucleocapsid still contain significant amounts of RNA - HIV/AIDS Screening
Prevalence of primary HIV infection estimated among symptomatic ambulatory patients - HIV/AIDS Seroconversion
HIV-1 variation determined within several weeks of estimated transmission - Diagnostics
HIV-associated cardiomyopathy can be detected early and may be effectively treated - Disease Control
High morbidity continues to be associated with diarrheal diseases - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
